Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease

Neurosci Lett. 2002 Aug 16;328(3):273-6. doi: 10.1016/s0304-3940(02)00547-5.

Abstract

A recent study has shown that a genetic variation in the Cathepsin D (catD) gene is a major risk factor for the development of Alzheimer's disease (AD). CatD is an intracellular aspartyl protease involved in neurodegeneration. A C-->T (Ala-->Val) transition at position 224 has been associated with altered intracellular maturation. Recently, a significant overrepresentation of the T allele of the catD gene in AD patients compared with controls was reported. However, this finding has not yet been confirmed. We analyzed the distribution of catD and apolipoprotein E polymorphisms in Italian patients with sporadic and familial AD (FAD). Our studies revealed that the distribution of catD polymorphism did not differ in AD and FAD patients and controls. Thus, our data do not support a role for the catD gene as a genetic risk factor in the development of AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / genetics*
  • Apolipoproteins E / genetics
  • Case-Control Studies
  • Cathepsin D / genetics*
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Polymorphism, Genetic*

Substances

  • Apolipoproteins E
  • Cathepsin D

Grants and funding